Remove 2022 Remove Drug Development Remove Life Science Remove Public Health
article thumbnail

Let’s Save the Date and Make Patient Engagement Official in 2022

Society for Participatory Medicine

Healthcare stakeholders such as health systems, pharmaceutical companies, biotech and life sciences firms, and insurance companies serve patients as end users. And I propose a toast: “To stop talking about involving patients and actually do it in 2022. Connect with her at [link]. Connect with her at [link].

BioTech 107
article thumbnail

AstraZeneca launches Evinova, a health-tech business to accelerate innovation across the life sciences sector, the delivery of clinical trials and better health outcomes

Digital Health Global

.–(BUSINESS WIRE)–AstraZeneca today launches Evinova, set to be a leading provider of digital health solutions to better meet the needs of healthcare professionals, regulators and patients. 2 Digital health is a large (+$900bn by 2032) and growing (13.6% CAGR 2022-2032) market. CAGR 2022-2032) market.